Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06373432 · ClinicalTrials.gov registry record · NA
Frequency of Glucose Monitoring in Labor
A NA study of Neonatal Hypoglycemia, sponsored by Icahn School of Medicine at Mount Sinai.
- Completed
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT06373432: Completed NA study of Neonatal Hypoglycemia, sponsored by Icahn School of Medicine at Mount Sinai.
NCT06373432 is a NA study of Neonatal Hypoglycemia that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 100 participants, below the 122-participant average among 5 other Neonatal Hypoglycemia trials with a reported enrollment target (18% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06373432, a NA study of Neonatal Hypoglycemia, has completed, sponsored by Icahn School of Medicine at Mount Sinai.
- COMPLETED
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
The aim of this study is to assess rates of neonatal hypoglycemia with differing intrapartum glucose protocols. Currently at this time there is no guidance from professional medical organizations about when and how frequent to assess maternal glucose levels intrapartum. Several institutions have no protocols in place. The study will be a randomized controlled trial placing patients with Gestational Diabetes Mellitus (GDM) in "frequent" vs "infrequent" glucose monitoring intrapartum and assessing neonatal glucose levels at birth.
Primary Outcome
Glucose values of neonate measured in mg/dL
Conditions Studied
Interventions
- OTHER Fingerstick
Study Locations (1)
New York
- Mount Sinai West Hospital - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2024-05-01 |
| Est. Completion | 2025-05-30 |
| Phase | NA |
What the finished NCT06373432 record still lists
NCT06373432 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 122-participant average among 5 other Neonatal Hypoglycemia trials with a reported enrollment target (18% lower).
The record links to 1 condition, with Neonatal Hypoglycemia appearing as the primary indexed condition, and to 1 intervention - of which Fingerstick is the first listed.
NCT06373432 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT06373432 about?
NCT06373432 is a clinical study titled "Frequency of Glucose Monitoring in Labor". The aim of this study is to assess rates of neonatal hypoglycemia with differing intrapartum glucose protocols. Currently at this time there is no guidance from professional medical organizations about when and how frequent to assess maternal glucose levels intrapartum. Several institutions have no ...
What is the current status of trial NCT06373432?
This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2024-05-01. Estimated completion is 2025-05-30.
What conditions does trial NCT06373432 study?
This clinical trial studies the following conditions: Neonatal Hypoglycemia.
What interventions are being tested in trial NCT06373432?
The interventions under investigation include: Fingerstick (OTHER).
Who is sponsoring clinical trial NCT06373432?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06373432 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Neonatal Hypoglycemia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Intrapartum Glucose Control and Risk of Neonatal Hypoglycemia
RECRUITING · NA
-
The Feasibility of Cream for Treatment of Neonatal Hypoglycemia
RECRUITING · NA
-
Continuous Glucose Monitoring in At-Risk Newborns
RECRUITING · NA
-
Effectiveness of Donor Human Milk Supplementation for the Treatment of Hypoglycemia in the Breastfed Infant
COMPLETED · NA
-
Continuous Glucose Monitoring in Infants
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI